STJ  St. Jude Medical Inc.

Exchange

NYSE

Sector

Health Care

Industry

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Cap.

19.215B

Vuru Grade

63.93/100

Current Price

$66.51
+0.48 (+0.73%)

Growth Price

$38.98
Overvalued by 41.40%

Stability Price

$20.19
Overvalued by 69.65%

Company Metrics

  • 21.27 P/E
  • 3.42 P/S
  • 4.73 P/B
  • 3.104 EPS
  • 13.07% Cash ROIC
  • 0.99 Cash Ratio
  • 1.04 / 1.58 % Dividend
  • 1.66M Avg. Vol.
  • 288.90M Shares
  • 19.215B Market Cap.

Company Description

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantab...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

St. Jude Medical Announces CE Mark Approval and First Use of the FlexAbility ...
MarketWatch - Jul 22, 2014
St. Jude Medical is a global medical device manufacturer dedicated to transforming the treatment of some of the world's most expensive epidemic diseases.
St. Jude Medical, Inc. Declares Quarterly Dividend of $0.27 (STJ)
Ticker Report - 18 hours ago
St. Jude Medical logo St. Jude Medical (NYSE:STJ) announced a quarterly dividend on Tuesday, July 29th, AnalystRatingsNetwork.
St. Jude Medical Announces Third Quarter Dividend - Business Wire (press release)
September 20th Options Now Available For St. Jude Medical (STJ)
Forbes - Jul 21, 2014
Investors in St. Jude Medical, Inc. (NYSE: STJ) saw new options begin trading today, for the September 20th expiration.
St. Jude Medical Announces Definitive Agreement to Acquire NeuroTherm
MarketWatch - Jul 14, 2014
WILMINGTON, Mass., Jul 14, 2014 (BUSINESS WIRE) -- St. Jude Medical, Inc. (NYSE:STJ) , a global medical device company, today announced that it has signed a definitive agreement to acquire privately held NeuroTherm, Inc., a manufacturer of ...
Layoffs at St. Jude Medical
San Fernando Valley Business Journal - Jul 24, 2014
St. Jude Medical Inc. will lay off up to 270 employees at its Sylmar heart-device manufacturing facility following a corporate restructuring.
St. Jude Medical Gets CE Mark for FlexAbility Catheter
Zacks.com - Jul 25, 2014
Shares of St. Jude Medical Inc. (STJ - Analyst Report) rose marginally following the announcement of receiving the Conformité Européenne (CE) Mark for its FlexAbility Ablation Catheter as well as its first use.
St. Jude Medical, Inc. Still Feeling the Love
Motley Fool - Jul 16, 2014
I thought St. Jude Medical (NYSE: STJ ) was already getting a fair bit of the benefit of the doubt back in April, but Wall Street has continued to bid these shares up on growing hopes that new products from the pipeline will drive revenue growth back ...
St. Jude Medical Hits New Lifetime High
Zacks.com - Jul 8, 2014
Shares of major medical devices manufacturer St. Jude Medical Inc. (STJ - Analyst Report) reached a new lifetime high of $71.90 in mid-day yesterday.
CRT Capital Initiates Coverage on St. Jude Medical (STJ) - WKRB News
St. Jude Medical Stock Rating Reaffirmed by Zacks (STJ) - Ticker Report
Tuesday's Analyst Moves: Costco Wholesale Corporation, Wal-Mart Stores, Inc ...
Dividend.com - Jul 29, 2014
Sterne Agee Initiates Coverage on St. Jude Medical. Sterne Agee has started coverage on St. Jude Medical, Inc. (STJ ) with a “Neutral” rating and $74 price target. This price target suggests a 10% upside from the stock's current price of $66.91. STJ ...
St. Jude Medical Profit More Than Doubles
Wall Street Journal - Jul 16, 2014
The St. Paul, Minn.-based company, which also raised its outlook for the year, has battled industrywide pressures—including pricing pressures from hospitals and insurers—in addition to regulatory and legal scrutiny regarding the frequency and ...
St. Jude Medical (STJ) Stock Is Down Despite Positive Earnings Results - TheStreet.com
St. Jude not keen to join inversion deal craze - Chicago Tribune (blog)